cardiostim - search results

If you're not happy with the results, please do another search

Cardiostim will not be held in 2018

Following EHRA’s decision to hold its own annual congress in March and the difficulty for the industry to financially support Cardiostim as well as...
Cardiac Rhythm news for specialists

EHRA EUROPACE‒CARDIOSTIM

W: www.escardio.org/EUROPACE

Abbott announces positive results for FIRM-guided rotor ablation at CARDIOSTIM 2016

Abbott has announced positive results from three clinical studies investigating the benefits associated with focal impulse rotor modulation (FIRM)-guided rotor ablation for atrial fibrillation. The...

St Jude Medical HeartMate 3 wins CARDIOSTIM-EHRA EUROPACE 2016 Innovation Award

St Jude Medical has received an Innovation Award for its HeartMate 3 left ventricular assist system (LVAS) at the 2016 CARDIOSTIM EHRA EUROPACE International...

Biotronik wins Cardiostim Innovation Award for Best Practice Improvement

Biotronik has won the Cardiostim Innovation Award in the category “Best Practice Improvement” for its MRI AutoDetect feature. The company’s Ilivia implantable cardioverter defibrillators (ICDs)...
Cardiac Rhythm news for specialists

Extravascular implantable cardioverter defibrillator data presented at CARDIOSTIM 2016

Results from several feasibility studies evaluating a new approach to implantable cardioverter defibrillator (ICD) therapy have been presented at CARDIOSTIM / EHRA EUROPACE  (8-11...

Stereotaxis to present Niobe ES at Cardiostim 2016

Stereotaxis is to present Niobe ES magnetic navigation system and supporting clinical evidence at Cardiostim-EHRA Europace 2016, taking place June 8-11 in Nice, France. William...
Cardiac Rhythm news for specialists

CARDIOSTIM-EHRA EUROPACE

W: www.cardiostim.com

Highlights EHRA EUROPACE-CARDIOSTIM 2015: Interview with Michael Glikson

Michael Glikson (director of Davidai Arrhythmia Center, Heart Center, Sheba Medical Center, Tel Hashomer, Israel), vice-chairperson scientific programme for EHRA EUROPACE-CARDIOSTIM 2015, talks to Cardiac Rhythm News about the highlights of this years' congress.
Cardiac Rhythm news for specialists

Preliminary positive data for Micra presented at Cardiostim/EHRA Europace

Preliminary results from the first four human procedures with the Micra Transcatheter Pacing System (Medtronic) have shown the device has been successfully implanted with no major complications post-implant.
Cardiac Rhythm news for specialists

Nanostim leadless pacemaker receives Cardiostim Innovation Award

The award, which was chosen by a congress committee of electrophysiologists and conveys the support of the electrophysiology community, recognises the Nanostim leadless pacemaker as the industry's most innovative product in the sector of electrophysiology and cardiac techniques.
Cardiac Rhythm news for specialists

Sensei X robotic catheter system to be featured at Cardiostim

The Sensei X2 features faster image processing and a slimmer design with the stability and reachability of its predecessor. The improved processing and imaging capabilities of the Sensei X2 will also be available to users of the current Sensei X upon release.

New consensus statement on CRT unveiled at Cardiostim

Cardiac Rhythm News talked to Jean-Claude Daubert, who is one of the founders of the European Heart Rhythm Association (EHRA), about key details of the new consensus statement on cardiac resynchronisation therapy (CRT) device implantation and follow-up.
Cardiac Rhythm news for specialists

Much debate over device infection study at Cardiostim

A study, which suggested that a novel therapy for managing cardiovascular implantable electronic device (CIED) infections could markedly diminish the need for device removal, sparked a lively discussion at Cardiostim (13-16 June, Nice, France).
Cardiac Rhythm news for specialists

ESC-EHRA and Cardiostim-Reed to hold a joint annual congress

The European Heart Rhythm Association (EHRA) a registered branch of the European Society of Cardiology (ESC) and Cardiostim"Reed have agreed to hold a joint annual congress during 2014"2017.
Cardiac Rhythm news for specialists

EPIC Alliance addresses hot topics for female electro-physiologists at Cardiostim 2012

The session will include electrophysiology-related presentations made by leading female physicians and researchers from around the world. Topics will include "Atrial fibrillation ablation: beyond pulmonary vein isolation" and "Controversies in lead extractions for noninfectious indications."
Cardiac Rhythm news for specialists

Zoll to showcase its LifeVest wearable defibrillator at Cardiostim

Zoll, manufacturer of the LifeVest wearable defibrillator and the RecueNet Medgate 12-Lead management solution, will display its products at Cardiostim (13-16 June, Nice, France) this week

Caucasians have a higher incidence of an out-of-hospital cardiac arrest but risk of death...

There is a lack of sufficient data about the effect of racial differences on outcomes following an out-of-hospital cardiac arrest. Therefore, Karuppiah Arunachalam and...

Repeat ablation with contact force sensing “does not necessarily guarantee a successful outcome” in...

Preliminary results from the ABLATOR observational registry have shown similar success rates (around 58%) in first time ablation and repeat ablation for persistent atrial...

EHRA Inventors Award ideas focus on cardiac remote monitoring and CRT optimisation

For the second-year running, the European Heart Rhythm Association (EHRA) held the EHRA Inventors Award competition at EHRA-EUROPACE CARDIOSTIM (18‒21 June, Vienna, Austria), a...

Europace 2017: Thrombus formation on left atrial appendage occlusion devices strongly associated with higher...

A French multicentre analysis of left atrial appendage (LAA) occlusion for stroke prevention in atrial fibrillation patients has found a 5.3% rate of thrombus...

Tenth edition of EHRA White Book of cardiac arrhythmia treatment data released

The tenth year of data on cardiac arrhythmia treatment is being launched at EHRA EUROPACE - CARDIOSTIM 2017. The edition marks the ten year anniversary...

Europace 2017: Breast implants may lead to false heart attack diagnosis

Breast implants may disrupt an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research presented at EHRA EUROPACE -...

App directs first responders to cardiac arrest three minutes before ambulance

A novel smartphone application (app) has been developed that can direct first responders to cardiac arrest victims more than three minutes before the emergency...

European Heart Rhythm Association congress to become annual in 2018

The scientific congresss of the European Heart Rhythm Association (EHRA) is to become an annual event from 2018. The next congress will take place...

Europace 2017: Stroke history higher in asymptomatic versus symptomatic atrial fibrillation patients

Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with symptoms, according to results from the GLORIA-AF registry...

Improved therapy and reduced healthcare costs demonstrated for Medtronic CRT devices

New data showing the use of Medtronic’s cardiac resynchronisation therapy (CRT) devices—with its proprietary AdaptivCRT and EffectiveCRT algorithms—to result in lower healthcare system costs...
Cardiac Rhythm news for specialists

Pacemakers and other cardiac devices can help solve forensic cases

Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at EHRA EUROPACE - CARDIOSTIM 2017. Devices revealed the...
Cardiac Rhythm news for specialists

Medtronic Reactive ATP therapy slows atrial fibrillation progression in real-world population

Medtronic has announced that its Reactive atrial-based antitachycardia pacing (ATP) therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices....

Christian Butter wins best abstract for SELECT-LV final trial results at pacing meeting in...

Christian Butter (Heart Center Brandenburg, Bernau bei Berlin, Germany) was awarded best abstract at the XVII International Symposium on Progress in Clinical Pacing (29...

Acute and chronic performance of communicating leadless anti-tachycardia pacemaker and S-ICD

Martin Burke (CorVita Science Foundation, Chicago, USA) presents the preclinical acute and chronic performance of the combined implant of a leadless anti-tachycardia pacemaker and...

EBR Systems receives FDA approval to begin IDE study of its wireless endocardial pacing...

EBR Systems has announced the US Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) for its WiSE (Wireless Stimulation Endocardially) technology for cardiac...

What we know about retrieval of leadless pacemakers

Given the early in-human experience with leadless pacemakers, safety and effectiveness of chronic retrieval of such devices is still under question. Reinoud Knops (Amsterdam,...

MultiPoint™ pacing CRT technology shows promise in improving heart failure responder rates

A growing body of evidence, including the most recent randomised clinical trial results presented at HRS and CARDIOSTIM-EHRA EUROPACE, has shown that cardiac resynchronisation therapy...

The OASIS trial: A critical appraisal

Recent results of the first randomised trial—OASIS trial—to compare rotor-only ablation with two other ablation strategies in non-paroxysmal atrial fibrillation patients found poor outcomes...

Cardiac resynchronisation therapy with SonR automated feature helps to reduce hospitalisation rates in heart...

Results from the RESPOND-CRT trial have shown a 35% risk reduction in hospitalisation at two years for heart failure patients implanted with cardiac resynchronisation...
Cardiac Rhythm news for specialists

Biotronik Edora pacemakers receive CE mark approval

Biotronik has received CE mark approval for its new Edora pacemakers and cardiac resynchronisation therapy pacemakers (CRT-Ps).Edora devices feature the Biotronik’s ProMRI (magnetic resonance...

Ablation of frequent premature ventricular complex allows safe withholding of ICD implant

Patients with frequent premature ventricular complex and primary prevention implantable cardioverter defibrillator (ICD) indication who undergo ablation may be able to avoid ICD implant,...

Fewer repeat ablations and hospitalisations with cryoballoon demonstrated in FIRE AND ICE

New data from the FIRE AND ICE clinical trial have shown significantly fewer repeat ablations and lower hospitalisation rates for patients with paroxysmal atrial...

Over 90% survival at one-year for patients using wearable defibrillator

The WEARIT-II prospective registry of more than 2,000 US patients has found over 90% survival rate at one-year in patients prescribed with the LifeVest...

Micra safety benefits sustained beyond six months

New results from the Medtronic Micra Transcatheter Pacing System (TPS) global clinical trial have been presented in a late-breaking trial session at CARDIOSTIM /...
michael glikson profile

Michael Glikson

Michael Glikson (Tel Hashomer, Israel) has contributed to the development of technologies for CRT, modern lead extraction, advanced mapping ablation of AF and VT and LAA occlusion. Glikson's current projects as president of the Israel Heart Society and co-president of the International Dead Sea Symposium (IDSS) on Innovations in Cardiac Arrhythmias and Device Therapy reflect his innovative approach in the field. He speaks to Cardiac Rhythm News about these projects, other highlights in his

First wireless cardiac pacing system for heart failure receives the CE mark

EBR Systems has announced the CE mark approval for its Wise (Wireless stimulation endocardially) technology, which is the world's only wireless endocardial pacing system for cardiac resynchronisation therapy (CRT).

Guideline-based algorithm helps to reduce syncope recurrence in old patients with severe syncopes

A sequential algorithm, which includes carotid sinus massage, tilt testing and implantable loop recorder implantation, helps to reduce syncope recurrence to 9% at one year in old patients with severe recurrent syncopes, according to results from the Syncope unit project 2 (SUP 2) study.

Sensor-based electromagnetic tracking system helps to improve resynchronisation therapy implant procedures

A sensor-based electromagnetic tracking system helps to improve cardiac resynchronisation therapy (CRT) implantation facilitating speed of the procedure, reducing exposure to radiation and improving success rate of access to the coronary sinus, according to a study presented at EHRA EUROPACE - CARDIOSTIM (21-24 June, Milan, Italy).

Safety, accuracy and validation of medical smartphone applications

The use of mobile smartphones and tablets that run applications (apps) to function as clinical examination tools, reference databases, technique guides, or medical calculators...

First ESC recommendations for arrhythmias and chronic kidney disease published

The first ESC recommendations for patients with cardiac arrhythmias and chronic kidney disease (CKD) were presented at EHRA EUROPACE - CARDIOSTIM 2015 (21-24 June, Milan, Italy) and published in EP Europace.
Cardiac Rhythm news for specialists

Patients “test drive” pacemaker before choosing permanent implant

Patients are "test driving" a pacemaker outside the skin before deciding whether to have a permanent implant, according to research presented at EHRA EUROPACE-CARDIOSTIM by Michael Giudici, University of Iowa Hospitals and Clinics, USA.

ESC recommends uninterrupted vitamin K antagonists during ablation and device implantation

The recommendations are an update of EHRA's 2008 consensus document, which required an update due to dramatic changes in the field during the last five years.

Cecilia Linde

Cecilia Linde speaks to Cardiac Rhythm News about her work on a research platform for new onset heart failure in Stockholm, the highlights of this year's EHRA EUROPACE - Cardiostim Congress and her views on what is needed to improve cardiac care in Europe.
Cardiac Rhythm news for specialists

Medtronic Micra transcatheter pacemaker meets initial safety and performance measures

The data from a global clinical trial involving the miniaturised device were presented at a late-breaking clinical trials session at EHRA EUROPACE-CARDIOSTIM 2015 (21-24 June, Milan, Italy).

Don’t miss Europe’s largest congress dedicated to cardiac arrhythmias

In June 2015, cardiac rhythm specialists will gather in Milan, Italy, to learn, share and discuss the latest advances in cardiac arrhythmias treatment in the largest European congress in the field: EHRA EUROPACE-CARDIOSTIM.

Antithrombotic therapy after left atrial appendage closure

Uncertainty exists about the optimal post-interventional antithrombotic drug regimen as well as treatment duration after left atrial appendage closure; Boris Schmidt and KR Julian...

Transseptal endocardial CRT: An evolving approach for heart failure patients

Néstor López Cabanillas and Elencwajg Benjamin from Buenos Aires, Argentina, write about two similar novel techniques for cardiac resynchronisation therapy (CRT) implantation, currently used...
Cardiac Rhythm news for specialists

First implants in largest-ever global trial of cardiac resynchronisation therapy

Medtronic has announced the first implants in a clinical trial that will compare patient and healthcare system outcomes in heart failure patients who have cardiac resynchronisation therapy (CRT) devices with the AdaptivCRT feature enabled versus patients receiving standard CRT.

Medtronic Viva CRT-P gets FDA approval

Medtronic has announced the US Food and Drug Administration (FDA) approval of its newest cardiac resynchronisation therapy-pacemaker, Viva CRT-P, for indicated patients with heart failure or atrioventricular block.

ANSWER study shows SafeR algorithm reduces right ventricular pacing and improves clinical outcomes in...

The ANSWER study evaluated whether the minimisation of Vp using the SafeR algorithm improves clinical outcomes for dual-chamber pacemaker patients implanted for sinus node disease or for atrio-ventricular block.

Wearable defibrillator registry (WEARIT-II) update

At Cardiostim/EHRA Europace (18-21 June, Nice, France), Ilan Goldenberg presented an update on one-year follow-up results from the prospective WEARIT-II registry of 1,404 patients using the Lifevest wearable cardioverter defibrillator (Zoll) who were enrolled in the USA from August 2011 through December 2013.
Cardiac Rhythm news for specialists

CRT-D devices with AdaptivCRT associated with reduction of costs of AF

New data from the Medtronic Adaptive CRT trial show a 61% (p=0.01) lower risk of atrial fibrillation (AF)-related problems in patients who receive a cardiac resynchronisation therapy-defibrillator (CRT-D) with the Medtronic-exclusive AdaptivCRT algorithm compared to conventional biventricular pacing therapy.
Cardiac Rhythm news for specialists

Schwarzer Cardiotek completes integration

Schwarzer Cardiotek has announced that it has completed the integration of the two companies. For the first time, the company showcased the combined portfolio of the merged entity and introduced its new corporate identity at Cardiostim/EHRA Europace (18-21 June, Nice, France).

Spectranetics receives CE mark for TightRail rotating dilator sheath platform

Spectranetics has announced receiving CE mark approval for its TightRail Rotating dilator sheath platform for mechanical cardiac lead extraction procedures.
Cardiac Rhythm news for specialists

Medtronic launches CardioGuide Implant System to guide cardiac resynchronisation therapy implants

The system helps physicians determine the most appropriate location for left-ventricular lead placement by generating 3-D images of the cardiac veins.

New insights into the basics of arrhythmias

Irene Savelieva and John Camm report on a session, which was co-chaired by Savelieva, at Cardiostim 2012 (13-16 June, Nice, France) about the latest information on the pathophysiology of arrhythmias.
Cardiac Rhythm news for specialists

Global and inferior J wave amplitudes associated with recurrent ventricular fibrillation

According to a study presented by Laurent Roten, Bordeaux, France, at Cardiostim, in patients with early repolarisation and who had survived a sudden cardiac arrest, global and inferior J wave amplitudes were significantly higher in patients with recurrent ventricular fibrillation than in the remaining patients.
Cardiac Rhythm news for specialists

Europe’s leading congresses in cardiac electrophysiology agree to develop a common scientific programme each...

Under the agreement, EHRA-Europace and Cardiostim share a wish to avoid fragmentation and create a common vision and objective - to promote the field of electrophysiology.
Cardiac Rhythm news for specialists

MADIT-CRT data show women received greater benefit from CRT-Ds than men

The sub-analysis demonstrated that both men and women experienced benefit from CRT but women experienced a 70% reduction in heart failure events compared to a 35% reduction for men.

Riccardo Cappato

Riccardo Cappato, from Milan, Italy, spoke to Cardiac Rhythm News about his career, advances in cardiac rhythm management, and his passion for crime fiction.
Cardiac Rhythm news for specialists

Cryoablation appears effective for paroxysmal but not persistent AF

The novel cryoballoon device (Arctic Front, Cryocath) appears safe and effective for patients with paroxysmal atrial fibrillation (AF), but not for those with persistent AF, according to German researchers.
Cardiac Rhythm news for specialists

AF-CHF trial results published

Results from the first trial to examine rhythm vs. rate control in heart failure patients with atrial fibrillation have been reported in the New England Journal of Medicine.

Athena Poppas

Eric Prystowsky

Eric N Prystowsky

Pedro Brugada